Terkko Navigator / Hematology/ Feeds

MicroRNA miR-34a downregulates FOXP1 during DNA damage response to limit BCR signalling in chronic lymphocytic leukaemia B cells

Emerging EZH2 Inhibitors and Their Application in Lymphoma

Small-Molecule Inhibitors for the Treatment of Diffuse Large B Cell Lymphoma

Rapid access clinic for unexplained lymphadenopathy and suspected malignancy: prospective analysis of 1000 patients

PROTON THERAPY FOR ADULTS WITH MEDIASTINAL LYMPHOMAS: THE INTERNATIONAL LYMPHOMA RADIATION ONCOLOGY GROUP (ILROG) GUIDELINES

Treatment of AL amyloidosis with bendamustine: a study of 122 patients

Next-generation sequencing based post-transplant monitoring of acute myeloid leukemia

Validation of the 2017 revision of the WHO chronic myelomonocytic leukemia categories

Neunert CE. Management of newly diagnosed immune thrombocytopenia: can we change outcomes? Blood Adv. 2017;1(24):2295-2301.

Highly cytotoxic natural killer cells are associated with poor prognosis in patients with cutaneous T-cell lymphoma

Application of a radiosensitivity flow assay in a patient with DNA ligase 4 deficiency

Mechanisms of establishment and functional significance of DNA demethylation during erythroid differentiation

Richardson PG, Carreras E, Iacobelli M, Nejadnik B. The use of defibrotide in blood and marrow transplantation. Blood Adv. 2018;2(12):1495-1509.

The molecular genetic background leading to the formation of the human erythroid-specific Xga/CD99 blood groups

Nivolumab-induced cold agglutinin syndrome successfully treated with rituximab

CD40L/IL-4-stimulated CLL demonstrates variation in translational regulation of DNA damage response genes including ATM

Amphiregulin modifies the Minnesota Acute Graft-versus-Host Disease Risk Score: results from BMT CTN 0302/0802

CXCR5 and ICOS expression identifies a CD8 T-cell subset with TFH features in Hodgkin lymphomas

Outcomes of patients who developed subsequent solid cancer after hematopoietic cell transplantation

Characterization of Tfrc-mutant mice with microcytic phenotypes

Inter-{alpha} inhibitor proteins maintain neutrophils in a resting state by regulating shape and reducing ROS production

A phase 1 trial evaluating thioridazine in combination with cytarabine in patients with acute myeloid leukemia

Cost-effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia in older adults without deletion 17p

Elevated ecto-5'-nucleotidase: a missing pathogenic factor and new therapeutic target for sickle cell disease

Double-blind, randomized, multicenter phase 2 study of SC411 in children with sickle cell disease (SCOT trial)

Development of a prognostically relevant cachexia index in primary myelofibrosis using serum albumin and cholesterol levels

Soluble PD-1 ligands regulate T-cell function in Waldenstrom macroglobulinemia

Induced pluripotent stem cell-based mapping of {beta}-globin expression throughout human erythropoietic development

How ibrutinib, a B-cell malignancy drug, became an FDA-approved second-line therapy for steroid-resistant chronic GVHD

Severe aplastic anemia: allogeneic bone marrow transplantation as first-line treatment

Dichloroacetate, an inhibitor of pyruvate dehydrogenase kinases, inhibits platelet aggregation and arterial thrombosis

The American Society of Hematology Honors Cage S. Johnson, MD, and José A. López, MD, with the ASH Award for Leadership in Promoting Diversity

The American Society of Hematology Honors John E. Dick, PhD, and Reed E. Drews, MD, for Outstanding Mentorship

The American Society of Hematology Honors Freda K. Stevenson, DPhil, and Brunangelo Falini, MD, with the 2018 Henry M. Stratton Medal

Alan D. D’Andrea, MD, and Neal S. Young, MD, to Present 2018 American Society of Hematology Ernest Beutler Lecture

Connie J. Eaves, PhD, to Present the 2018 American Society of Hematology E. Donnall Thomas Lecture

The American Society of Hematology Honors Victor Hoffbrand, DM, FRCP, FMed Sci, with the Wallace H. Coulter Award for Lifetime Achievement in Hematology

The American Society of Hematology Honors Ross L. Levine, MD, with the 2018 William Dameshek Prize

The emerging story of acute lymphoblastic leukemia among the latin American population – biological and clinical implications

Hypergranular lymphoblastic leukaemia

Abundant pseudo‐Gaucher cells result in delay in diagnosis of plasma cell myeloma

Dyserythropoiesis in the diagnosis of the myelodysplastic syndromes and other myeloid neoplasms: problem areas

Haploidentical haematopoietic stem cell transplantation for thalassaemia major based on an FBCA conditioning regimen

Elotuzumab monotherapy in patients with smouldering multiple myeloma: a phase 2 study

Second primary malignancy after multiple myeloma‐population trends and cause‐specific mortality

Oxidative stress and phosphatidylserine exposure in red cells from patients with sickle cell anaemia

Differential prognostic impact of GELTAMO‐IPI in cell of origin subtypes of Diffuse Large B Cell Lymphoma as defined by the Hans algorithm

Paediatric patients with acute leukaemia and KMT2A (MLL) rearrangement show a distinctive expression pattern of histone deacetylases

Evaluation of 230 patients with relapsed/refractory deletion 17p chronic lymphocytic leukaemia treated with ibrutinib from 3 clinical trials

Potential involvement of ubiquitin‐proteasome system dysfunction associated with oxidative stress in the pathogenesis of sickle cell disease